X0306 4 2021-11-01 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001724567 Schultz Kare C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST., TEL AVIV L3 6944020 ISRAEL 1 1 0 0 President and CEO Ordinary Shares 2021-11-01 4 M 0 180000 A 1040582 D Restricted Share Units 2021-11-01 4 M 0 180000 0.00 D Ordinary Shares 180000 116389 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on November 3, 2017, with 63,613 vested on November 3, 2019, 180,000 vested on each of November 1, 2020 and November 1, 2021 and 116,389 vesting on November 1, 2022. /s/ Dov Bergwerk as attorney-in-fact for Kare Schultz 2021-11-03